Hervé Remy

¹³¹ I Effective Half-Life and Dosimetry in Thyroid Cancer Patients

Hervé Remy, Isabelle Borget, Sophie Leboulleux et al. · Journal of Nuclear Medicine · 2008 · 120 citations · Full text

Medicine, Oncology, Pharmacokinetics +13

Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells

S. Hescot, Abdelhamid Slama, Anne Lombès et al. · Endocrine Related Cancer · 2013 · 96 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT

Séréna Grimaldi, Jacques Young, Peter Kamenický et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 83 citations · Full text

Medicine, Nuclear Medicine, Surgery +17

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen

Isabelle Borget, Hervé Remy, Julie Chevalier et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 70 citations

Medicine, Oncology, Surgery +9

Thyroid Cancer Patients Treated with ¹³¹ I: Radiation Dose to Relatives After Discharge from the Hospital

Hervé Remy, J. Coulot, Isabelle Borget et al. · Thyroid · 2011 · 19 citations

Medicine, Nuclear Medicine, Oncology +17